IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $30 | -99.9% | 87,412 | +1.0% | 0.00% | – |
Q3 2022 | $32,000 | -17.9% | 86,537 | -0.1% | 0.00% | – |
Q2 2022 | $39,000 | -9.3% | 86,662 | 0.0% | 0.00% | – |
Q1 2022 | $43,000 | -12.2% | 86,662 | 0.0% | 0.00% | – |
Q4 2021 | $49,000 | -44.9% | 86,662 | 0.0% | 0.00% | – |
Q3 2021 | $89,000 | -13.6% | 86,662 | 0.0% | 0.00% | – |
Q2 2021 | $103,000 | +114.6% | 86,662 | +130.9% | 0.00% | – |
Q1 2021 | $48,000 | -50.5% | 37,537 | +40.8% | 0.00% | – |
Q4 2020 | $97,000 | +120.5% | 26,662 | +27.5% | 0.00% | – |
Q3 2020 | $44,000 | +18.9% | 20,912 | -0.0% | 0.00% | – |
Q2 2020 | $37,000 | +37.0% | 20,915 | 0.0% | 0.00% | – |
Q1 2020 | $27,000 | -28.9% | 20,915 | -0.1% | 0.00% | – |
Q4 2019 | $38,000 | -36.7% | 20,940 | 0.0% | 0.00% | – |
Q3 2019 | $60,000 | +9.1% | 20,940 | 0.0% | 0.00% | – |
Q2 2019 | $55,000 | +14.6% | 20,940 | +9.3% | 0.00% | – |
Q1 2019 | $48,000 | -9.4% | 19,150 | 0.0% | 0.00% | – |
Q4 2018 | $53,000 | -68.8% | 19,150 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $170,000 | – | 19,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 486,604 | $1,348,000 | 0.18% |
SPHERA FUNDS MANAGEMENT LTD. | 445,558 | $1,234,000 | 0.14% |
Baker Brothers Advisors | 4,836,237 | $13,396,000 | 0.11% |
Kassirer Asset Management Corp | 19,341 | $54,000 | 0.05% |
Quantitative Systematic Strategies LLC | 23,427 | $65,000 | 0.02% |
MYCIO WEALTH PARTNERS, LLC | 55,815 | $155,000 | 0.01% |
Assenagon Asset Management S.A. | 416,241 | $1,153,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 165,626 | $459,000 | 0.01% |
Candriam S.C.A. | 290,000 | $803,000 | 0.01% |
ZACKS INVESTMENT MANAGEMENT | 168,781 | $468,000 | 0.01% |